This page contains brief information about fedratinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Fedratinib hydrochloride is approved for use in adults to treat:
- Myelofibrosis (a bone marrow disease) that is intermediate-2 risk or high risk, including the following types:
Fedratinib hydrochloride is also being studied in the treatment of other conditions.
More About Fedratinib Hydrochloride
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Fedratinib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.